Freely Filtered, a NephJC Podcast

Freely Filtered 030: DAPA-CKD

03.15.2021 - By NephJC TeamPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

The DAPA program busted SGLT2i out of the diabetes paradigm by showing that dapagliflozen improved heart failure and CKD outcomes in a patients with or without diabetes.

More episodes from Freely Filtered, a NephJC Podcast